Stockscreener 앱 받기
1.41
0.71%
0.01
시간 외 거래:
1.42
0.01
+0.71%
전일 마감가:
$1.40
열려 있는:
$1.4
하루 거래량:
82,163
Relative Volume:
0.68
시가총액:
$6.19M
수익:
$3.19M
순이익/손실:
$-10.42M
주가수익비율:
-0.1455
EPS:
-9.69
순현금흐름:
$-10.65M
1주 성능:
-2.09%
1개월 성능:
-14.02%
6개월 성능:
-23.37%
1년 성능:
-64.37%
1일 변동 폭
$1.37
$1.46
1주일 범위
$1.3313
$1.46
52주 변동 폭
$1.00
$11.70
Intelligent Bio Solutions Inc Stock (INBS) Company Profile
명칭
Intelligent Bio Solutions Inc
전화
646-233-6971
주소
135 W 41ST ST,, NEW YORK
INBS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
INBS
Intelligent Bio Solutions Inc
|
1.41 | 6.19M | 3.19M | -10.42M | -10.65M | -35.48 |
|
ABT
Abbott Laboratories
|
113.44 | 196.76B | 41.22B | 5.77B | 6.49B | 3.29 |
|
SYK
Stryker Corp
|
358.72 | 136.75B | 21.97B | 3.59B | 3.21B | 9.33 |
|
BSX
Boston Scientific Corp
|
89.38 | 131.73B | 15.91B | 1.79B | 1.89B | 1.21 |
|
MDT
Medtronic Plc
|
80.22 | 102.86B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
72.59 | 42.81B | 6.60B | 4.16B | 490.10M | 6.93 |
Intelligent Bio Solutions Inc 주식(INBS)의 최신 뉴스
How maker of drug tests Intelligent Bio Solutions builds its business on people’s tendency to lie - Kursiv Media
Intelligent Bio Solutions (NASDAQ:INBS) Stock Quotes, Forecast and News Summary - Benzinga
Intelligent Bio Solutions Submits FDA Premarket Notification - TipRanks
Intelligent Bio Gains On Applying For Fingerprinting Review - Barchart
Intelligent Bio Gains on Applying for Fingerprinting Review - Baystreet.ca
INBS seeks FDA clearance for fingerprint drug test - Investing.com
Intelligent Bio Solutions Inc. Submits FDA 510(k) Application for Intelligent Fingerprinting Drug Screening System - Nasdaq
Intelligent Bio Solutions Announces 510(k) Submission to US - GlobeNewswire
Intelligent Bio Solutions Files FDA Application for 94% Accurate 10-Minute Drug Screening Breakthrough - StockTitan
Intelligent Bio Solutions Announces Positive Results of PK Study, a Key Milestone on Path to FDA 510(k) Submission - Marketscreener.com
Intelligent Bio Solutions to Host Virtual Fireside Chat on Wednesday, December 11th at 4:30 p.m. ET - Marketscreener.com
Intelligent Bio Solutions CEO to Discuss FDA Path & Clinical Results in Upcoming Fireside Chat - StockTitan
Intelligent Bio Solutions Releases Business Operations Presentation - TipRanks
Intelligent Bio Solutions completes fingerprint drug screening system study - MSN
Intelligent Bio Solutions Advances Fingerprint Drug Testing - TipRanks
Intelligent Bio : Achieves 94.1% Accuracy in Method Comparison Study, Following Positive PK Study Results Form 8 K - Marketscreener.com
Intelligent Bio Solutions Achieves 94.1% Accuracy in Method Comparison Study, Following Positive PK Study Results - The Manila Times
Intelligent Bio Solutions Hits 94% Accuracy in Drug Screening Breakthrough Study - StockTitan
Intelligent Bio Solutions to Participate in the Noble Capital Markets 20th Annual Emerging Growth Equity Conference - Marketscreener.com
Intelligent Bio Solutions to Participate in the Noble Capital Markets' 20th Annual Emerging Growth Equity Conference - The Manila Times
Intelligent Bio Solutions to Participate in the Noble Capital Markets’ 20th Annual Emerging Growth Equity Conference - Marketscreener.com
Intelligent Bio Solutions to Present at Noble Capital's 2024 Growth Conference | INBS Stock News - StockTitan
Intelligent Bio Solutions raises $250k via stock sales - Investing.com
Intelligent Bio Solutions raises $250k via stock sales By Investing.com - Investing.com Canada
INBS (Intelligent Bio Solutions) Peter Lynch Fair Value : $-443.54 (As of Nov. 21, 2024) - GuruFocus.com
INBS (Intelligent Bio Solutions) Inventory Turnover : 0.69 (As of Sep. 2024) - GuruFocus.com
Intelligent Bio Solutions Announces Study Results and Stock Sale - TipRanks
INBS (Intelligent Bio Solutions) Price-to-Free-Cash-Flow : N/A (As of Nov. 20, 2024) - GuruFocus.com
INBS (Intelligent Bio Solutions) Net Issuance of Preferred Stock : $0.00 Mil (TTM As of Sep. 2024) - GuruFocus.com
Intelligent Bio : INBS PK Study Results Video - Marketscreener.com
INBS (Intelligent Bio Solutions) EBITDA per Share : $-30.36 (TTM As of Sep. 2024) - GuruFocus.com
INBS (Intelligent Bio Solutions) Total Assets : $11.73 Mil (As of Sep. 2024) - GuruFocus.com
INBS (Intelligent Bio Solutions) PensionAndRetirementBenefi - GuruFocus.com
INBS (Intelligent Bio Solutions) Price-to-Operating-Cash-Fl - GuruFocus.com
INBS Stock Declines Despite Positive Results of Pharmacokinetic Study - MSN
Alyeska Investment Group's Strategic Acquisition of Intelligent Bio Solutions Inc Shares - GuruFocus.com
Intelligent gears up for FDA approval of fingerprint drug detection device - Yahoo Finance
INBS advances in drug detection with fingerprint technology By Investing.com - Investing.com Australia
Intelligent Bio Solutions Inc. Announces Positive Results of PK Study, a Key Milestone on Path to FDA 510(k) Submission - Marketscreener.com
INBS advances in drug detection with fingerprint technology - Investing.com
Intelligent Bio Solutions (INBS) Announces Positive Results of PK Study, a Key Milestone on Path to FDA 510(k) Submission - StreetInsider.com
Intelligent Bio Solutions Hits Major Breakthrough in Drug Detection Study, FDA Filing Next | INBS Stock News - StockTitan
Intelligent Bio Solutions First Quarter 2025 Earnings: US$0.70 loss per share (vs US$12.49 loss in 1Q 2024) - Yahoo Finance
Intelligent Bio Solutions Inc. (INBS) Quarterly 10-Q Report - Quartzy
INBSIntelligent Bio Solutions Inc. Latest Stock News & Market Updates - StockTitan
Integra Lifesciences (IART) Stock Sees Sharp 5.09% Decline Amid Market Fluctuations - GuruFocus.com
INTELLIGENT BIO SOLUTIONS INC. SEC 10-Q Report - TradingView
Intelligent Bio Solutions Reports Fiscal 2025 First Quarter Financial Results and Operational Highlights - The Manila Times
ConnectM to Participate in the 13th Annual Roth Technology Conference - The Manila Times
Intelligent Bio Solutions Revenue Surges 20% QoQ, FDA Study Milestone Achieved | INBS Stock News - StockTitan
Intelligent Bio Solutions Inc (INBS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.51%
0.94%
자본화:
|
볼륨(24시간):